|Last Price$84.65||Day Change (%)0.18%|
|Open Price$84.73||Day Change ($)0.15|
|Day Range84.01–84.83||52-Week Range51.47–92.35|
As of Thu 12/19/2013 04:00 PM EST | USD
Kcentra®, from CSL Behring, Receives FDA Approval for Use in Warfarin Reversal in Patients Undergoing Surgery
CSL Behring Study Shows Kcentra® Superior to Plasma for Warfarin Reversal in Patients Requiring an Urgent Surgical Procedure
Prologis Declares Quarterly Dividends
Nevsun Announces Commercial Production on Bisha Copper Expansion
Research and Markets: OTC Market in CIS Countries 2013 - Russia, Ukraine & Kazakhstan
Hurricane Electric Significantly Expands Global Internet Backbone Reach in Eastern Europe with Six New Internet Exchange Connections
Prologis, L.P. to Offer Guaranteed Notes due 2022
Hamid Moghadam, Chairman & CEO of Prologis, Named National EY Entrepreneur Of The Year™ 2013 Overall Award Winner
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.
Rabobank finally settles on a buyer for most of Robeco, Fidelity to close Fidelity Small Cap Value, Matthews Asia to launch 2 new funds, and Victory Capital gains independence.